Skip to main content
mSphere logoLink to mSphere
. 2020 Nov 4;5(6):e00963-20. doi: 10.1128/mSphere.00963-20

Spo0A Suppresses sin Locus Expression in Clostridioides difficile

Babita Adhikari Dhungel a, Revathi Govind a,
Editor: Craig D Ellermeierb
PMCID: PMC7643835  PMID: 33148827

Clostridioides difficile is the leading cause of antibiotic-associated diarrheal disease in the United States. During infection, C. difficile spores germinate, and the vegetative bacterial cells produce toxins that damage host tissue. In C. difficile, the sin locus is known to regulate both sporulation and toxin production. In this study, we show that Spo0A, the master regulator of sporulation, controls sin locus expression. Results from our study suggest that Spo0A directly regulates the expression of this locus by binding to its upstream DNA region. This observation adds new detail to the gene regulatory network that connects sporulation and toxin production in this pathogen.

KEYWORDS: Clostridioides difficile, C. difficile, SinR, Spo0A, gene regulation, virulence gene regulation

ABSTRACT

Clostridioides difficile is the leading cause of nosocomial infection and is the causative agent of antibiotic-associated diarrhea. The severity of the disease is directly associated with toxin production, and spores are responsible for the transmission and persistence of the organism. Previously, we characterized sin locus regulators SinR and SinR′ (we renamed it SinI), where SinR is the regulator of toxin production and sporulation. The SinI regulator acts as its antagonist. In Bacillus subtilis, Spo0A, the master regulator of sporulation, controls SinR by regulating the expression of its antagonist, sinI. However, the role of Spo0A in the expression of sinR and sinI in C. difficile had not yet been reported. In this study, we tested spo0A mutants in three different C. difficile strains, R20291, UK1, and JIR8094, to understand the role of Spo0A in sin locus expression. Western blot analysis revealed that spo0A mutants had increased SinR levels. Quantitative reverse transcription-PCR (qRT-PCR) analysis of its expression further supported these data. By carrying out genetic and biochemical assays, we show that Spo0A can bind to the upstream region of this locus to regulates its expression. This study provides vital information that Spo0A regulates the sin locus, which controls critical pathogenic traits such as sporulation, toxin production, and motility in C. difficile.

IMPORTANCE Clostridioides difficile is the leading cause of antibiotic-associated diarrheal disease in the United States. During infection, C. difficile spores germinate, and the vegetative bacterial cells produce toxins that damage host tissue. In C. difficile, the sin locus is known to regulate both sporulation and toxin production. In this study, we show that Spo0A, the master regulator of sporulation, controls sin locus expression. Results from our study suggest that Spo0A directly regulates the expression of this locus by binding to its upstream DNA region. This observation adds new detail to the gene regulatory network that connects sporulation and toxin production in this pathogen.

INTRODUCTION

Clostridioides difficile is a Gram-positive, anaerobic bacillus and is the principal causative agent of antibiotic-associated diarrhea and pseudomembranous colitis (13). Antibiotic use is the primary risk factor for the development of C. difficile-associated disease because it disrupts normal protective gut flora and provides a favorable environment for C. difficile to colonize the colon. Two major pathogenic traits of C. difficile are toxins (toxins A and B) and spores (35). Deaths related to C. difficile increased by 400% between 2000 and 2007, in part because of the emergence of more aggressive C. difficile strains (6, 7). Robust sporulation and toxin production were suspected of contributing to widespread C. difficile infections associated with these highly virulent strains (814). How C. difficile triggers toxin production and sporulation in the intestinal environment is only beginning to be understood.

We recently reported the identification and characterization of master regulator SinR in C. difficile, which was found to regulate sporulation, toxin production, and motility (15). SinR in the Gram-positive model organism Bacillus subtilis is well characterized and is known to regulate multiple pathways, including sporulation, competence, motility, and biofilm formation (1618). In B. subtilis, SinR is encoded by the downstream gene of the two-gene operon called the sin (sporulation inhibition) locus, and its transcription is driven from two promoters. The second gene in the operon, sinR, is transcribed by an internal promoter and is constitutively expressed. SinR represses the first committed (stage II) genes in the sporulation pathway (17). The promoter upstream of the operon is activated by phosphorylated Spo0A, leading to the expression of sinI, along with sinR. The SinI protein binds and inhibits the DNA binding activity of SinR (1921). The combined effect of positive regulation by phosphorylated SpoA (Spo0A∼P) and the inactivation of the negative regulator SinR activates the sporulation pathway. In C. difficile also, the sin locus is a two-gene operon and encodes SinR and SinI (previously SinR′). In our initial characterization of the C. difficile sin locus, we showed that disruption of the sin locus (absence of both SinR and SinI) resulted in an asporogenic, less toxic, and less motile phenotype (15). Another study, which reports that C. difficile sin locus suppresses biofilm formation, corroborates our finding (22). Further investigation showed that among the two regulators, SinR positively influences sporulation, toxin production, and motility, while SinI acts as an antagonist to SinR and controls its activity (15). Since the sin locus has a role in regulating various pathogenic traits in C. difficile, understanding the regulation of its expression is important. Earlier, we showed that disruption of the first gene in the operon, sinR, affects transcription of both sinR and the downstream gene sinI. This observation led to the assumption that unlike B. subtilis, the C. difficile sin locus is transcribed from a single upstream promoter. Real-time reverse transcription-PCR (RT-PCR) analysis of the cells grown in vitro showed sin locus expression at the 10-h time point, indicating its tight regulation (15). From various gene expression data, we can observe that mutations in sigH and spo0A positively influence the expression of sinRI (2326) and mutations in tcdR act to downregulate their expression (27). We have also demonstrated that CodY can directly bind to the sin locus upstream DNA to transcriptionally repress its expression (15). In the same line of investigation, in this study, we discovered that Spo0A, the sporulation master regulator, represses sin locus expression. The effect was directly caused by the specific binding of Spo0A to the promoter region upstream of the locus.

RESULTS

An elevated level of SinR is present in the spo0A mutant.

In C. difficile, we have previously shown that the sin locus mutant is asporogenic and this phenotype is associated with downregulation of spo0A expression. Interestingly, disruption of sinI, the second gene in the locus, resulted in elevated levels of sporulation. This result suggested that SinR is a positive regulator of sporulation. Gene expression data from spo0A mutants from different studies have shown elevated levels of sin locus expression compared to their respective parents (25, 28, 29). These observations taken together suggest that these two master regulators, Spo0A and SinR, regulate each other’s transcription. To understand the possible regulatory relationship between SinR and Spo0A in C. difficile, we created spo0A mutants in two different C. difficile strains, JIR8094 and UK1, using the ClosTron mutagenesis technique. Mutation in spo0A was confirmed by PCR (see Fig. S1 in the supplemental material) and Western blot analysis using Spo0A-specific antibodies (Fig. 1B). The spo0A R20291 mutant, obtained from the Dena Lyras lab (30), was also included in the study. As previously reported, the mutation in spo0A resulted in the asporogenic phenotype (24, 25, 30, 31). For complementation, plasmid pRG312 carrying spo0A under its own promoter was introduced into the mutants. Heat-resistant spores were observed in the complemented strains; however, the levels were significantly lower than those in the wild type (see Fig. S2 in the supplemental material). To test whether Spo0A influences the expression of the sin locus genes, we performed quantitative reverse transcription-PCR (qRT-PCR) analysis of the sinR and sinI transcripts in spo0A mutants and complemented strains, as well as among their respective parent strains. As previously reported, the levels of sinR and sinI transcripts were increased several-fold (Fig. 1A) in all three spo0A mutants compared to their parent strains. An approximately 2-fold reduction in the sinR and sinI transcripts could be observed in the complemented strains. To further confirm this result, we performed Western blot analysis using SinR-specific antibodies. We grew the mutants and the respective parent strains in TY (tryptose and yeast extract) medium for 10 h and observed the levels of SinR in their cytosol. We found that spo0A mutants of all three strains produced larger amounts of SinR compared to their respective parents (Fig. 1B). However, in our complementation of JIR8094::spo0A and UK1::spo0A, we observed a partial reduction of SinR levels (Fig. 1B). Reduction in SinR level was not obvious in the R20291::spo0A complemented strain. Failures to complement an spo0A mutation had been previously observed in C. difficile. Two independent studies showed incomplete restoration of the sporulation phenotype in R20291::spo0A (28, 30). However, when Deakin et al. tested the spo0A mutants of 630Δerm and R20291 strains, they found in vitro levels of sporulation to be restored to wild-type levels in their complemented derivative (31). When they tested the R20291 strains for toxin production, however, the complemented strain still produced increased toxin levels compared to the wild type (31). These observations suggest that introducing spo0A using a multicopy plasmid may not be a suitable method for complementation considering the Spo0A regulatory networks’ complex nature. In a recent study, Dembek et al. successfully placed Ptet regulatory elements upstream of the spo0A gene, generating 630erm::PtetSpo0A. This strain can be artificially induced to sporulate by adding anhydrotetracycline (ATc) (32). We obtained this strain and performed SinR Western blotting upon induction of Spo0A. A reduction in sinR and sinI transcription levels could be seen as Spo0A production increases (Fig. 2A). This observation was further confirmed by Western blot analysis of the Spo0A-induced cultures with SinR-specific antibodies. These results together suggest Spo0A as a negative regulator of the sin locus (Fig. 2B).

FIG 1.

FIG 1

In the absence of Spo0A, C. difficile produces elevated levels of SinR. (A) qRT-PCR results of sin locus transcripts in C. difficile strains collected at the 10-h time point. The representative results from three independent experiments are shown. The asterisks (***) indicate statistical difference at P < 0.005. (B) Western blot analysis of parent strains (R20291, JIR8094, and UK01) and their respective spo0A mutants and complemented strains using SinR- and Spo0A-specific antibodies, demonstrating upregulated SinR in the absence of Spo0A. The sinR mutant served as a negative control. Glutamate dehydrogenase (GDH) detection using anti-GDH antibodies was used as loading control.

FIG 2.

FIG 2

Spo0A suppresses sin locus expression in the 630erm::PtetSpo0A strain in a dose-dependent manner. (A) qRT-PCR analysis of sinR, sinI, and spo0A transcripts from the 630erm::PtetSpo0A strain grown with increasing concentrations of ATc for 10 h. (B) Western blots of protein extracts from the induced cultures. Coomassie-stained gel is provided as a loading control.

FIG S1

Construction and confirmation of the spo0A mutant in the C. difficile JIR8094 and UK1 strains. (A) Schematic representation of ClostTron (group II intron)-mediated insertional inactivation of the spo0A gene in C. difficile. (B) PCR verification of the intron insertion and complementation of spo0A in JIR8094 with the intron-specific EBS universal primer [EBS(U)] and with spo0A-specific primers ORG 551 and ORG 552. (C) PCR verification of the intron insertion in the UK1 strain with EBS(U), ORG 551, and ORG 552. Download FIG S1, TIF file, 1.1 MB (1.1MB, tif) .

Copyright © 2020 Dhungel and Govind.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

FIG S2

Sporulation in spo0A mutants. Shown is the percentage of sporulation (the CFU/ml from ethanol-resistant spores) of the parent strain and spo0A mutants. The representative results from three independent experiments are shown. Download FIG S2, TIF file, 0.1 MB (76.9KB, tif) .

Copyright © 2020 Dhungel and Govind.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

Spo0A represses sin locus expression.

Spo0A is a transcriptional regulator and is a DNA binding protein. Spo0A binds to specific DNA sequences in the promoter region of its target gene to regulate their expression. To determine if the elevated levels of SinR observed in spo0A mutants are due to the repressor activity of Spo0A, we performed reporter fusion assays. We fused 600 bp of the sin locus upstream DNA with the gusA reporter gene coding for β-glucuronidase, and the construct was introduced into the R2091::spo0A mutant and its parent strain. The plasmid carrying a promoterless gusA gene was used as a negative control. We also cloned the promoter region of spoIIAB, known to be regulated by Spo0A, with the gusA gene and used this construct as a positive control. The spoIIAB promoter is positively regulated by Spo0A and was found to be active only in the parent strain and not in the spo0A mutant (Fig. 3A). We observed significantly higher β-glucuronidase activity when it was expressed from the sin locus promoter in the R20291::spo0A mutant strain compared to the parent strain, where very minimal reporter activity was recorded. This observation is consistent with our Western blot results, where we detected elevated levels of SinR in spo0A mutant strains. Taken together, these results suggest that Spo0A represses the transcription of sinR either directly or indirectly. To narrow down the Spo0A-controlled region in the sin locus promoter, we cloned 475 and 340 bp of the upstream DNA with the gusA gene and performed the reporter fusion assays. The levels of reporter gene activity were similar in the cultures carrying the 600- and 340-bp upstream fusions (Fig. 3B). This result indicates that both the sin locus promoter and the Spo0A-regulated regions are present within this 340-bp region.

FIG 3.

FIG 3

Spo0A represses sin locus expression. (A) β-Glucuronidase activity of the Psin-gusA fusions in the parent strain R20291 and R20291::spo0A mutant. Plasmid pBA038 has gusA as the reporter gene fused to 600 bp of sin locus upstream. A plasmid carrying PspoIIAB-gusA (pBA029) and a plasmid carrying a promoterless gusA gene (pBA040) were used as positive and negative controls, respectively. (B) Expression of β-glucuronidase in parent strain R20291 and the spo0A mutant carrying plasmids pBA037 (475-bp Psin-gusA), pBA038 (600-bp Psin-gusA), and pBA009 (340-bp Psin-gusA). The error bars in panels A and B correspond to standard errors of the means of results from 3 biological replicates, where ** and *** indicate P < 0.05 and P < 0.005, respectively (by two-tailed Student's t test). At least three independent experiments were performed.

Spo0A binds to the sin locus upstream region.

The results in Fig. 3A and B show that expression of Psin-gusA was lower in the R20291 background, while the expression of the reporter gene was at higher levels in the R20291::spo0A background. To determine whether the repression of sinR by Spo0A is due to Spo0A binding specifically to the promoter region of sinR, we carried out a DNA binding experiment. Considering that Spo0A needs to be phosphorylated to bind to the target DNA, we did not attempt the in vitro electrophoretic gel shift assay. Instead, we used a biotin-labeled DNA pulldown assay to determine the DNA binding ability of Spo0A under native conditions. The DNA segment representing the promoter region of sinR was biotinylated and was coupled to immobilized monomeric avidin resin. This bead-DNA complex was incubated with the cell lysate from the parent R20291 strain. The bound proteins were eluted, run in SDS-PAGE, and immunoblotted with the Spo0A antibody. We first standardized the binding experiment by using the spo0IIAB promoter region as a positive control. Spo0A protein could be detected in the eluates when the spo0IIAB upstream DNA was used as the bait. The biotinylated gluD upstream DNA and the beads alone were also processed similarly and served as negative controls. We applied the same protocol using the biotinylated 340-bp sin upstream DNA as bait. The results showed that it could pull down Spo0A, suggesting that Spo0A binds specifically to the promoter region of the sin locus (Fig. 4A and B). Next, to narrow down the Spo0A binding site within that 340 bp, we created three biotin-labeled fragments covering the first 118 bp (340 to 222 bp upstream), the last 140 bp, and the overlapping 135-bp midregion (237 to 102 bp upstream) (Fig. 4A and C) and used them as bait in the pulldown experiment. Spo0A was detected when the 140-bp midregion and the first 118 bp were used as baits (Fig. 4C). Since the biotin-labeled DNA pulldown assay is semiquantitative, this assumption needs further validation. Spo0A could not be recovered from the eluate from the binding of the gluD upstream region or with beads alone (not shown), suggesting the specificity of the Spo0A binding with the sin locus promoter.

FIG 4.

FIG 4

(A) Spo0A binds to sin locus upstream DNA. Shown are schematics of the 340-bp upstream sin locus denoting the general locations of the M1, M2, R1, and R2 sequences (not to scale) with respect to the translation start (+1) of sinR. The lower lines indicate the location and the sizes of the DNA fragments used for the biotinylated-DNA pulldown assay. (B) Western blot analysis using Spo0A-specific antibody to detect endogenous Spo0A in input and eluate fractions. For the biotin-labeled DNA pulldown assay, the promoter regions of spoIIAB and gluD were used as positive and negative controls, respectively. (C) Three DNA fragments (118, 135, and 140 bp) spanning different regions of the 340-bp sin locus upstream were used independently to carry out the binding, and Spo0A was detected as in panel B. (D) Expression of β-glucuronidase in parent strain R20291 and R20291::spo0A mutant strains carrying plasmids with gusA as the reporter gene fused to the wild-type and mutated promoters of sinR. A strain carrying a promoterless gusA plasmid (pBA040) was used as a control. Data represent the means ± standard errors of the means (n = 3). The asterisks (***) in panel A indicate statistical difference at P < 0.005 (by two-tailed Student's t test). NS, not significant.

Mutational analysis of the sinR upstream region.

In B. subtilis, Spo0A∼P is known to bind to the 7-bp DNA element 5′-TGNCGAA-3′, commonly known as the Spo0A box (33). However, there are certain exceptions in which Spo0A binds to degenerated Spo0A boxes with mismatches in the upstream region of some targets (34, 35). The DNA binding domain of C. difficile Spo0A is highly homologous to B. subtilis Spo0A, and the key residues of Spo0A known to mediate the interaction with the bases of the 0A box are highly conserved in Bacillus and Clostridium species (24, 36). In C. difficile, Spo0A is known to bind to spo0A upstream and sigH upstream. Both of these genes have the TGTCGAA consensus Spo0A box sequence (23, 37). C. difficile Spo0A also binds upstream of an spoIIAA-spoIIE-spoIIGA operon with low affinity, where the binding sequence is a degenerated Spo0A box with TACGACA sequence (23). We scanned the upstream region of sinR for potential Spo0A binding consensus sequence. We could predict that Spo0A binds to sequences within the 340 to 102 bp upstream of the sin locus from the biotin pulldown experiment. A classical Spo0A binding box (TTCTACA, complementary to TGTAGAA [marked as R1]) could be identified 274 bp upstream of the start codon. A potential degenerated Spo0A box (TTCGTTT [marked as R2]) was located 230 bp upstream. Two repeats with TATTGTAG sequences could also be seen in this region. We included all four regions for further analysis. We mutated the C and G residues in these chosen regions with T, and these mutated sin upstream regions were used to create reporter fusions. Mutations in the repeat sequences didn’t affect the expression of the reported genes. However, mutations in the predicted Spo0A boxes (R1 and R2) affected the expression of the reporter fusion (Fig. 4D). These mutations relieved the repression observed in the parent strain, and the reporter activity was similar to the one observed in the spo0A mutant. To further confirm this result, we performed a biotin pulldown assay with the sin locus upstream DNA carrying both the R1 and R2 mutations. Spo0A couldn’t be pulled down when this mutated DNA fragment was used as a bait (Fig. 4B). These results demonstrate that Spo0A binds to the R1 and R2 regions in the sin locus upstream to repress its expression.

DISCUSSION

Sporulation in a cell is an intense response to stress and is particularly expensive in both time and materials (38). The exact conditions and timing for sporulation are likely to be under strong selective pressure as both premature spore production and belated production can have disastrous effects on cell growth and survival. In B. subtilis, the sin (sporulation inhibition) operon is central to the timing and early dynamics of this network (3941), and its regulation is controlled by the sporulation master regulator Spo0A itself. In this study, we have demonstrated that similar to B. subtilis, the sin locus in C. difficile is also regulated by Spo0A.

Like in many Gram-positive bacteria, Spo0A is the master regulator of sporulation in C. difficile (24, 30, 31). When the post-exponential phase begins, Spo0A activates the expression of the genes involved in the sporulation initiation process and positively regulates the sigma factor cascade required for sporulation (29). In many other pathogenic spore-forming bacteria, the gene regulatory networks that influence sporulation and virulence are closely linked with each other (4246). In C. difficile, the mutation in spo0A affected many pathogenic traits, including toxin production, flagellum expression, and biofilm formation (5, 28, 30, 31, 47). Mackin et al. observed a clear increase in the production of toxins A and B upon disruption of spo0A in the ribotype 027 isolates R20291 and M7404 (30). In a similar study, Deakin et al. found that an R20291 spo0A mutant caused more severe disease in a murine model than the wild-type strain and associated this increase in severity with an increase in the amount of toxins A and B produced by the mutant in vitro (31). Dawson et al. showed that Spo0A in the 630Δerm strain promotes a sporulation cascade and biofilm formation and negatively regulates expression of virulence factors (toxins and flagella) (28). We found the UK1::spo0A strain to produce higher levels of toxins than its parent strain, while no significant difference was observed between the JIR8094 parent and JIR8094::spo0A mutant (see Fig. S3A in the supplemental material). This observation was consistent with the previous report, where a mutation in spo0A influenced the toxin production only in the 027 ribotype, which includes the UK1 and R20291 strains, but not in the 630Δerm strain, which belongs to the 012 ribotype like the JIR8094 strain. Reduced biofilm formation was also found only in R20291::spo0A and UK1::spo0A (Fig. S3B and C). The mechanism of Spo0A regulation over these pathways remains to be answered. In the C. difficile genome, >100 open reading frames have potential 0A boxes within 500 bp of their start codons, indicating direct regulation by Spo0A (24). However, tcdA and tcdB, encoding toxins A and B, respectively, are not among them, indicating the indirect influence of Spo0A on toxin production (24). Spo0A could indirectly control motility and biofilm formation since many candidate regulators are encoded by the genes putatively under the direct control of Spo0A in C. difficile (24, 31). Our current finding of Spo0A-mediated sin locus regulation can partly explain many of the phenotypes displayed by spo0A mutants, especially in the ribotype 027 strains (28, 30). In our initial characterization of the sin locus, we showed decreased toxin production and motility in the absence of SinR and SinI (15). The expression of sinR alone was sufficient to complement these phenotypes and suggested SinR as a positive regulator of these pathways (15). We have further shown that SinR controls toxin production by regulating sigD, a sigma factor that positively regulates tcdR, which is needed for the transcription of toxin genes (15, 48, 49). SigD is also needed for the transcription of the flagellar operon in C. difficile (48, 49). This study has shown increased SinR production in the absence of Spo0A (Fig. 1A and B). qRT-PCR results showed increased expression of sigD, tcdR, and tcdB in the R20291::spo0A and UK1::spo0A strains compared to their respective parent strains (Fig. S3C). Increased sigD expression can lead to increased flagellar and toxin production and reduced biofilm formation in the spo0A mutant (22, 28) (Fig. S3).

FIG S3

Toxin gene transcription and biofilm formation in the R20291::spo0A mutant strain. (A) Toxin production measured by ELISA. Statistical analysis was performed using Student’s t test. (**, P < 0.05). (B) Crystal violet-stained biofilm in the 12-well tissue culture plate, showing poor biofilm formation in the R20291::spo0A and UK1::spo0A mutants. (C) Relative expression of the transcripts of tcdR, tcdB, and sigD genes from C. difficile. RNA was collected from the parent and spo0A mutant strains in the JIR8094, R20291, and UK1 backgrounds at the 10-h time point. Download FIG S3, TIF file, 0.2 MB (256.6KB, tif) .

Copyright © 2020 Dhungel and Govind.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

In this study, we have shown that Spo0A binds to the C. difficile sin locus promoter and suppresses the expression of both sinR and sinI. We had previously shown that disruption of sinR by insertion mutagenesis affects transcription of both sinR and sinI (15), suggesting that sinRI is transcribed as a bicistronic message. Our qRT-PCR analysis detected lower levels of sinI transcripts than sinR transcripts. Since the reduction is observed in both the parent strain and spo0A mutants, we can conclude that this effect is independent of Spo0A.

In summary, we have demonstrated that Spo0A, the master regulator of sporulation, regulates sin locus expression. We have further shown that Spo0A can bind to the upstream region of the sin locus and have successfully mapped the region to which it binds. This finding adds a new detail to C. difficile’s virulence gene regulatory network.

MATERIALS AND METHODS

Bacterial strains and growth conditions.

C. difficile strains (see Table S1 in the supplemental material) were grown in TY (tryptose and yeast extract) agar or broth culture in an anaerobic chamber maintained at 10% H2, 10% CO2, and 80% N2 as described previously (27, 5052). Lincomycin (Lin; 20 μg/ml) and thiamphenicol (Thio; 15 μg/ml) were added to the culture medium when required. S17-1, an Escherichia coli strain used for conjugation (53), was cultured aerobically in LB (Luria-Bertani) broth or agar and was supplemented with ampicillin (100 μg/ml) or chloramphenicol (25 μg/ml) when necessary.

TABLE S1

Bacterial strains and plasmids used in this study. Download Table S1, DOCX file, 0.02 MB (22.6KB, docx) .

Copyright © 2020 Dhungel and Govind.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

General DNA techniques.

Chromosomal DNA was extracted from C. difficile cultures with the DNeasy blood and tissue kit (Qiagen). PCRs were carried out using gene-specific primers (see Table S2 in the supplemental material). PCR products were extracted from the gel with the Geneclean kit (mpbio). Plasmid DNA was extracted using the QIAprep spin miniprep kit (Qiagen). Standard procedures were used to perform routine cloning.

TABLE S2

Oligonucleotides used in the study. Download Table S2, DOCX file, 0.02 MB (18KB, docx) .

Copyright © 2020 Dhungel and Govind.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

Construction and complementation of C. difficile spo0A mutant strains.

The spo0A mutants of the JIR8094 and UK1 strains were created using the ClosTron gene knockout system as described previously (24, 25, 28, 31). Briefly, for spo0A disruption, the group II intron insertion site between nucleotides 178 and 179 in the spo0A gene in the antisense orientation was selected using a web-based design tool called the Perutka algorithm. The designed retargeted intron was cloned into pMTL007-CE5, as described previously (54). The resulting plasmid, pMTL007-CE5::spo0A-178-179a, was transferred into C. difficile UK1 and JIR8094 cells by conjugation. The potential Ll.ltrB insertions within the target genes were conferred by the selection of lincomycin-resistant transconjugants in 20-μg/ml lincomycin plates. PCR using gene-specific primers (Table S2) in combination with the EBS(U) universal primer was performed to identify putative C. difficile mutants. C. difficile spo0A mutants were complemented by introducing pRG312, which contains the spo0A gene with the 300-bp upstream region, through conjugation. Complementation was confirmed by PCR and Western blot analysis.

Western blot analysis.

C. difficile cultures for Western blot analysis were harvested and washed in 1× phosphate-buffered saline (PBS) solution. The pellets were resuspended in sample buffer (80 mM Tris, 2% SDS, 10% glycerol) and lysed by sonication. The whole-cell extracts were then centrifuged at 17,000 × g at 4°C for 1 min. The lysate was heated at 100°C for 7 min, and the proteins were separated by SDS-PAGE and electroblotted onto polyvinylidene difluoride (PVDF) membrane. The blots were then probed with specific primary and secondary antibodies at a dilution of 1:10,000. Immunodetection of proteins was done using the ECL enhanced chemiluminescence kit (Millipore) following the manufacturer’s recommendations and were developed using the G-Box iChemi XR scanner. Blot images were overlapped with the original images of the membrane to visualize the prestained marker.

Construction of reporter plasmids and β-glucuronidase assay.

The sin locus upstream DNA regions of various lengths were amplified by PCR using specific primers with KpnI and SacI (Table S2) recognition sequences. R20291 strain chromosomal DNA was used as a template for this amplification. Plasmid pRPF185 carries a gusA gene for β-glucuronidase under a tetracycline-inducible (tet) promoter. The tet promoter was removed using KpnI and SacI digestion and was replaced with sin locus upstream regions of various lengths to create plasmids pBA009, pBA029, pBA037, pBA038, and pBA039 (Table S1). The control plasmid pBA040 with a promoterless gusA gene was created by digestion with KpnI and SacI to remove the tet promoter and then self-ligated after creating blunt ends. Plasmids were introduced into the R20291 and R20291::spo0A strains through conjugation as described previously (15, 27). The transconjugants were grown in TY medium in the presence of thiamphenicol (15 μg/ml) overnight. These overnight cultures were then used as an inoculum at a 1:100 dilution to start a new culture. Bacterial cultures were harvested at 10 h of growth, and the amount of β-glucuronidase activity was assessed as described elsewhere (55, 56).

Mutagenesis of sin locus promoter region.

A Quick Change Lightning site-directed mutagenesis kit (Agilent Technologies) was used to carry out site-directed mutagenesis whereby G and C residues of the potential Spo0A binding 0A boxes were substituted for with A residues. The mutagenic oligonucleotide primers used are listed in Table S2. Synthetic DNA fragments with R1 and R2 mutations (Fig. 4A) were delivered cloned into pUC57 by Genewiz, which were later used to create reporter fusions and for the biotin pulldown assays.

Biotin pulldown assays.

Biotin pulldown assays were carried out as described elsewhere (57). Briefly, the PsinR DNA fragment was biotin labeled and was coupled to immobilized monomeric avidin resin (G Biosciences) in B/W buffer (57). PgluD (upstream of gluD coding for glutamate dehydrogenase) and bead-alone negative controls were treated alongside test samples. The DNA and the beads were incubated at room temperature for 30 min in a rotor. The bead-DNA complex was washed with TE buffer to remove any unbound DNA. To prepare cell lysates, C. difficile R20291 strain was grown to the late exponential phase (16 h) in 500 ml TY medium at pH 7.4. After washing with 1× PBS, the cells were resuspended in BS/THES buffer (57) and lysed using a French press. The whole lysate was centrifuged at 20,000 × g for 30 min at 4°C. The supernatant, along with salmon sperm DNA as a nonspecific competitor, was incubated with the bead-DNA complex and allowed to rotate at 4°C overnight. The bead-DNA-protein complex was washed with BS/THES buffer (5 times). Elution was carried out with 50, 100, and 200 mM NaCl in Tris-HCl at pH 7.4. The eluates were analyzed by SDS-PAGE and Western blotting using Spo0A-specific antibody.

TEXT S1

Supplemental methods: sporulation assay, toxin assays, qRT-PCR, and biofilm assay. Download Text S1, DOCX file, 0.02 MB (17.5KB, docx) .

Copyright © 2020 Dhungel and Govind.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

TABLE S3

Oligonucleotides used for qRT-PCR. Download Table S3, DOCX file, 0.01 MB (14.7KB, docx) .

Copyright © 2020 Dhungel and Govind.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

ACKNOWLEDGMENTS

We thank the following investigators for sharing their lab resources: Nigel Minton, University of Nottingham, for the plasmids pMTL007C-E5 and pMTL84151; Robert Fagan for the vector pRPF185; and Paula Salgado for the 630erm::PtetSpo0A C. difficile strain. We thank Yusuf Ciftici for technical assistance throughout the study.

R.G. is supported by NIAID (1R15AI122173 and 1R03AI135762-01A1). Funds from the Johnson Cancer Center—KSU and a pilot project to R.G. from CBID-KU (1P20GM113117-01) also supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

REFERENCES

  • 1.Guh AY, Kutty PK. 2018. Clostridioides difficile infection. Ann Intern Med 169:ITC49–ITC64. doi: 10.7326/AITC201810020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Prete RD, Ronga L, Addati G, Magrone R, Abbasciano A, Decimo M, Miragliotta G. 2019. Clostridium difficile. a review on an emerging infection. La Clinica Terapeutica 1:e41–e47. [DOI] [PubMed] [Google Scholar]
  • 3.Awad MM, Johanesen PA, Carter GP, Rose E, Lyras D. 2014. Clostridium difficile virulence factors: insights into an anaerobic spore-forming pathogen. Gut Microbes 5:579–593. doi: 10.4161/19490976.2014.969632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Schäffler H, Breitrück A. 2018. Clostridium difficile—from colonization to infection. Front Microbiol 9:646. doi: 10.3389/fmicb.2018.00646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Underwood S, Guan S, Vijayasubhash V, Baines SD, Graham L, Lewis RJ, Wilcox MH, Stephenson K. 2009. Characterization of the sporulation initiation pathway of Clostridium difficile and its role in toxin production. J Bacteriol 191:7296–7305. doi: 10.1128/JB.00882-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.CDC. 2013. Antibiotic resistance threats in the United States, 2013. https://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf.
  • 7.Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, Farley MM, Holzbauer SM, Meek JI, Phipps EC, Wilson LE, Winston LG, Cohen JA, Limbago BM, Fridkin SK, Gerding DN, McDonald LC. 2015. Burden of Clostridium difficile infection in the United States. N Engl J Med 372:825–834. doi: 10.1056/NEJMoa1408913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Depestel DD, Aronoff DM. 2013. Epidemiology of Clostridium difficile infection. J Pharm Pract 26:464–475. doi: 10.1177/0897190013499521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Akerlund T, Persson I, Unemo M, Noren T, Svenungsson B, Wullt M, Burman LG. 2008. Increased sporulation rate of epidemic Clostridium difficile type 027/NAP1. J Clin Microbiol 46:1530–1533. doi: 10.1128/JCM.01964-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.O’Connor JR, Johnson S, Gerding DN. 2009. Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology 136:1913–1924. doi: 10.1053/j.gastro.2009.02.073. [DOI] [PubMed] [Google Scholar]
  • 11.Camacho-Ortiz A, López-Barrera D, Hernández-García R, Galván-De Los Santos AM, Flores-Treviño SM, Llaca-Díaz JM, Maldonado-Garza HJ, Garza HJM, Bosques-Padilla FJ, Garza-González E. 2015. First report of Clostridium difficile NAP1/027 in a Mexican hospital. PLoS One 10:e0122627. doi: 10.1371/journal.pone.0122627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Giancola SE, Williams RJ, Gentry CA. 2018. Prevalence of the Clostridium difficile BI/NAP1/027 strain across the United States Veterans Health Administration. Clin Microbiol Infect 24:877–881. doi: 10.1016/j.cmi.2017.11.011. [DOI] [PubMed] [Google Scholar]
  • 13.Fatima R, Aziz M. 2019. The hypervirulent strain of Clostridium difficile: NAP1/B1/027—a brief overview. Cureus 11:e3977. doi: 10.7759/cureus.3977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Stabler RA, He M, Dawson L, Martin M, Valiente E, Corton C, Lawley TD, Sebaihia M, Quail MA, Rose G, Gerding DN, Gibert M, Popoff MR, Parkhill J, Dougan G, Wren BW. 2009. Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biol 10:R102. doi: 10.1186/gb-2009-10-9-r102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Girinathan BP, Ou J, Dupuy B, Govind R. 2018. Pleiotropic roles of Clostridium difficile sin locus. PLoS Pathog 14:e1006940. doi: 10.1371/journal.ppat.1006940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Kearns DB, Chu F, Branda SS, Kolter R, Losick R. 2005. A master regulator for biofilm formation by Bacillus subtilis. Mol Microbiol 55:739–749. doi: 10.1111/j.1365-2958.2004.04440.x. [DOI] [PubMed] [Google Scholar]
  • 17.Cervin MA, Lewis RJ, Brannigan JA, Spiegelman GB. 1998. The Bacillus subtilis regulator SinR inhibits spoIIG promoter transcription in vitro without displacing RNA polymerase. Nucleic Acids Res 26:3806–3812. doi: 10.1093/nar/26.16.3806. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Mandic-Mulec I, Doukhan L, Smith I. 1995. The Bacillus subtilis SinR protein is a repressor of the key sporulation gene spo0A. J Bacteriol 177:4619–4627. doi: 10.1128/jb.177.16.4619-4627.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Bai U, Mandic-Mulec I, Smith I. 1993. SinI modulates the activity of SinR, a developmental switch protein of Bacillus subtilis, by protein-protein interaction. Genes Dev 7:139–148. doi: 10.1101/gad.7.1.139. [DOI] [PubMed] [Google Scholar]
  • 20.Milton ME, Draughn GL, Bobay BG, Stowe SD, Olson AL, Feldmann EA, Thompson RJ, Myers KH, Santoro MT, Kearns DB, Cavanagh J. 2019. The solution structures and interaction of SinR and SinI: elucidating the mechanism of action of the master regulator switch for biofilm formation in Bacillus subtilis. J Mol Biol 432:343–357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Shafikhani SH, Mandic-Mulec I, Strauch MA, Smith I, Leighton T. 2002. Postexponential regulation of sin operon expression in Bacillus subtilis. J Bacteriol 184:564–571. doi: 10.1128/jb.184.2.564-571.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Poquet I, Saujet L, Canette A, Monot M, Mihajlovic J, Ghigo J-M, Soutourina O, Briandet R, Martin-Verstraete I, Dupuy B. 2018. Clostridium difficile biofilm: remodeling metabolism and cell surface to build a sparse and heterogeneously aggregated architecture. Front Microbiol 9:2084. doi: 10.3389/fmicb.2018.02084. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Saujet L, Monot M, Dupuy B, Soutourina O, Martin-Verstraete I. 2011. The key sigma factor of transition phase, SigH, controls sporulation, metabolism, and virulence factor expression in Clostridium difficile. J Bacteriol 193:3186–3196. doi: 10.1128/JB.00272-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Rosenbusch KE, Bakker D, Kuijper EJ, Smits WK. 2012. C. difficile 630Δerm Spo0A regulates sporulation, but does not contribute to toxin production, by direct high-affinity binding to target DNA. PLoS One 7:e48608. doi: 10.1371/journal.pone.0048608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Pettit LJ, Browne HP, Yu L, Smits W, Fagan RP, Barquist L, Martin MJ, Goulding D, Duncan SH, Flint HJ, Dougan G, Choudhary JS, Lawley TD. 2014. Functional genomics reveals that Clostridium difficile Spo0A coordinates sporulation, virulence and metabolism. BMC Genomics 15:160. doi: 10.1186/1471-2164-15-160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Nawrocki KL, Edwards AN, Daou N, Bouillaut L, McBride SM. 2016. CodY-dependent regulation of sporulation in Clostridium difficile. J Bacteriol 198:2113–2130. doi: 10.1128/JB.00220-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Girinathan BP, Monot M, Boyle D, McAllister KN, Sorg JA, Dupuy B, Govind R. 2017. Effect of tcdR mutation on sporulation in the epidemic Clostridium difficile strain R20291. mSphere 2:e00383-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Dawson LF, Valiente E, Faulds-Pain A, Donahue EH, Wren BW. 2012. Characterisation of Clostridium difficile biofilm formation, a role for Spo0A. PLoS One 7:e50527. doi: 10.1371/journal.pone.0050527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Fimlaid KA, Bond JP, Schutz KC, Putnam EE, Leung JM, Lawley TD, Shen A. 2013. Global analysis of the sporulation pathway of Clostridium difficile. PLoS Genet 9:e1003660. doi: 10.1371/journal.pgen.1003660. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Mackin KE, Carter GP, Howarth P, Rood JI, Lyras D. 2013. Spo0A differentially regulates toxin production in evolutionarily diverse strains of Clostridium difficile. PLoS One 8:e79666. doi: 10.1371/journal.pone.0079666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Deakin LJ, Clare S, Fagan RP, Dawson LF, Pickard DJ, West MR, Wren BW, Fairweather NF, Dougan G, Lawley TD. 2012. The Clostridium difficile spo0A gene is a persistence and transmission factor. Infect Immun 80:2704–2711. doi: 10.1128/IAI.00147-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Dembek M, Willing SE, Hong HA, Hosseini S, Salgado PS, Cutting SM. 2017. Inducible expression of spo0A as a universal tool for studying sporulation in Clostridium difficile. Front Microbiol 8:1793. doi: 10.3389/fmicb.2017.01793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Asayama M, Yamamoto A, Kobayashi Y. 1995. Dimer form of phosphorylated Spo0A, a transcriptional regulator, stimulates the spo0F transcription at the initiation of sporulation in Bacillus subtilis. J Mol Biol 250:11–23. doi: 10.1006/jmbi.1995.0354. [DOI] [PubMed] [Google Scholar]
  • 34.Baldus JM, Green BD, Youngman P, Moran CP. 1994. Phosphorylation of Bacillus subtilis transcription factor Spo0A stimulates transcription from the spoIIG promoter by enhancing binding to weak 0A boxes. J Bacteriol 176:296–306. doi: 10.1128/jb.176.2.296-306.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Chen G, Kumar A, Wyman TH, Moran CP. 2006. Spo0A-dependent activation of an extended −10 region promoter in Bacillus subtilis. J Bacteriol 188:1411–1418. doi: 10.1128/JB.188.4.1411-1418.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Molle V, Fujita M, Jensen ST, Eichenberger P, González-Pastor JE, Liu JS, Losick R. 2003. The Spo0A regulon of Bacillus subtilis. Mol Microbiol 50:1683–1701. doi: 10.1046/j.1365-2958.2003.03818.x. [DOI] [PubMed] [Google Scholar]
  • 37.Saujet L, Pereira FC, Henriques AO, Martin-Verstraete I. 2014. The regulatory network controlling spore formation in Clostridium difficile. FEMS Microbiol Lett 358:1–10. doi: 10.1111/1574-6968.12540. [DOI] [PubMed] [Google Scholar]
  • 38.Hutchison EA, Miller DA, Angert ER. 2014. Sporulation in bacteria: beyond the standard model. Microbiol Spectr 2. doi: 10.1128/microbiolspec.TBS-0013-2012. [DOI] [PubMed] [Google Scholar]
  • 39.Grossman AD. 1995. Genetic networks controlling the initiation of sporulation and the development of genetic competence in Bacillus subtilis. Annu Rev Genet 29:477–508. doi: 10.1146/annurev.ge.29.120195.002401. [DOI] [PubMed] [Google Scholar]
  • 40.Gaur NK, Dubnau E, Smith I. 1986. Characterization of a cloned Bacillus subtilis gene that inhibits sporulation in multiple copies. J Bacteriol 168:860–869. doi: 10.1128/jb.168.2.860-869.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Gaur NK, Cabane K, Smith I. 1988. Structure and expression of the Bacillus subtilis sin operon. J Bacteriol 170:1046–1053. doi: 10.1128/jb.170.3.1046-1053.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Dale JL, Raynor MJ, Ty MC, Hadjifrangiskou M, Koehler TM. 2018. A dual role for the Bacillus anthracis master virulence regulator AtxA: control of sporulation and anthrax toxin production. Front Microbiol 9:482. doi: 10.3389/fmicb.2018.00482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Deng C, Peng Q, Song F, Lereclus D. 2014. Regulation of cry gene expression in Bacillus thuringiensis. Toxins (Basel) 6:2194–2209. doi: 10.3390/toxins6072194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Dürre P. 2014. Physiology and sporulation in Clostridium. Microbiol Spectr 2. doi: 10.1128/microbiolspec.TBS-0010-2012. [DOI] [PubMed] [Google Scholar]
  • 45.Li J, Paredes-Sabja D, Sarker MR, McClane BA. 2016. Clostridium perfringens sporulation and sporulation-associated toxin production. Microbiol Spectr 4. doi: 10.1128/microbiolspec.TBS-0022-2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Mi E, Li J, McClane BA. 2018. NanR regulates sporulation and enterotoxin production by Clostridium perfringens type F strain F4969. Infect Immun 86:e00416-18. doi: 10.1128/IAI.00416-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Ðapa T, Dapa T, Leuzzi R, Ng YK, Baban ST, Adamo R, Kuehne SA, Scarselli M, Minton NP, Serruto D, Unnikrishnan M. 2013. Multiple factors modulate biofilm formation by the anaerobic pathogen Clostridium difficile. J Bacteriol 195:545–555. doi: 10.1128/JB.01980-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.El Meouche I, Peltier J, Monot M, Soutourina O, Pestel-Caron M, Dupuy B, Pons J-L. 2013. Characterization of the SigD regulon of C. difficile and its positive control of toxin production through the regulation of tcdR. PLoS One 8:e83748. doi: 10.1371/journal.pone.0083748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.McKee RW, Mangalea MR, Purcell EB, Borchardt EK, Tamayo R. 2013. The second messenger cyclic di-GMP regulates Clostridium difficile toxin production by controlling expression of sigD. J Bacteriol 195:5174–5185. doi: 10.1128/JB.00501-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Girinathan BP, Braun SE, Govind R. 2014. Clostridium difficile glutamate dehydrogenase is a secreted enzyme that confers resistance to H2O2. Microbiology (Reading) 160:47–55. doi: 10.1099/mic.0.071365-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Girinathan BP, Braun S, Sirigireddy AR, Lopez JE, Govind R. 2016. Importance of glutamate dehydrogenase (GDH) in Clostridium difficile colonization in vivo. PLoS One 11:e0160107. doi: 10.1371/journal.pone.0160107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Govind R, Dupuy B. 2012. Secretion of Clostridium difficile toxins A and B requires the holin-like protein TcdE. PLoS Pathog 8:e1002727. doi: 10.1371/journal.ppat.1002727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Teng F, Murray BE, Weinstock GM. 1998. Conjugal transfer of plasmid DNA from Escherichia coli to enterococci: a method to make insertion mutations. Plasmid 39:182–186. doi: 10.1006/plas.1998.1336. [DOI] [PubMed] [Google Scholar]
  • 54.Heap JT, Pennington OJ, Cartman ST, Carter GP, Minton NP. 2007. The ClosTron: a universal gene knock-out system for the genus Clostridium. J Microbiol Methods 70:452–464. doi: 10.1016/j.mimet.2007.05.021. [DOI] [PubMed] [Google Scholar]
  • 55.Dupuy B, Sonenshein AL. 1998. Regulated transcription of Clostridium difficile toxin genes. Mol Microbiol 27:107–120. doi: 10.1046/j.1365-2958.1998.00663.x. [DOI] [PubMed] [Google Scholar]
  • 56.Mani N, Lyras D, Barroso L, Howarth P, Wilkins T, Rood JI, Sonenshein AL, Dupuy B. 2002. Environmental response and autoregulation of Clostridium difficile TxeR, a sigma factor for toxin gene expression. J Bacteriol 184:5971–5978. doi: 10.1128/jb.184.21.5971-5978.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Jutras BL, Verma A, Stevenson B. 2012. Identification of novel DNA-binding proteins using DNA-affinity chromatography/pull down. Curr Protoc Microbiol Chapter 1:Unit1F.1. doi: 10.1002/9780471729259.mc01f01s24. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

FIG S1

Construction and confirmation of the spo0A mutant in the C. difficile JIR8094 and UK1 strains. (A) Schematic representation of ClostTron (group II intron)-mediated insertional inactivation of the spo0A gene in C. difficile. (B) PCR verification of the intron insertion and complementation of spo0A in JIR8094 with the intron-specific EBS universal primer [EBS(U)] and with spo0A-specific primers ORG 551 and ORG 552. (C) PCR verification of the intron insertion in the UK1 strain with EBS(U), ORG 551, and ORG 552. Download FIG S1, TIF file, 1.1 MB (1.1MB, tif) .

Copyright © 2020 Dhungel and Govind.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

FIG S2

Sporulation in spo0A mutants. Shown is the percentage of sporulation (the CFU/ml from ethanol-resistant spores) of the parent strain and spo0A mutants. The representative results from three independent experiments are shown. Download FIG S2, TIF file, 0.1 MB (76.9KB, tif) .

Copyright © 2020 Dhungel and Govind.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

FIG S3

Toxin gene transcription and biofilm formation in the R20291::spo0A mutant strain. (A) Toxin production measured by ELISA. Statistical analysis was performed using Student’s t test. (**, P < 0.05). (B) Crystal violet-stained biofilm in the 12-well tissue culture plate, showing poor biofilm formation in the R20291::spo0A and UK1::spo0A mutants. (C) Relative expression of the transcripts of tcdR, tcdB, and sigD genes from C. difficile. RNA was collected from the parent and spo0A mutant strains in the JIR8094, R20291, and UK1 backgrounds at the 10-h time point. Download FIG S3, TIF file, 0.2 MB (256.6KB, tif) .

Copyright © 2020 Dhungel and Govind.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

TABLE S1

Bacterial strains and plasmids used in this study. Download Table S1, DOCX file, 0.02 MB (22.6KB, docx) .

Copyright © 2020 Dhungel and Govind.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

TABLE S2

Oligonucleotides used in the study. Download Table S2, DOCX file, 0.02 MB (18KB, docx) .

Copyright © 2020 Dhungel and Govind.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

TEXT S1

Supplemental methods: sporulation assay, toxin assays, qRT-PCR, and biofilm assay. Download Text S1, DOCX file, 0.02 MB (17.5KB, docx) .

Copyright © 2020 Dhungel and Govind.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

TABLE S3

Oligonucleotides used for qRT-PCR. Download Table S3, DOCX file, 0.01 MB (14.7KB, docx) .

Copyright © 2020 Dhungel and Govind.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.


Articles from mSphere are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES